This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_KIDNEY_NOTRENALPELVIS_EXALLC for full statistics.
Malignant neoplasm of kidney, except renal pelvis
C3_KIDNEY_NOTRENALPELVIS
kidney neoplasm: A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3414 |
4. Check minimum number of eventsNone |
3414 |
5. Include endpoints |
3414 |
6. Filter based on genotype QC (FinnGen only) |
3414 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of kidney, except renal pelvis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3414 | 1230 | 2184 |
| Unadjusted period prevalence (%) | 0.77 | 0.42 | 0.96 |
| Median age at first event (years) | 66.29 | 65.45 | 66.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3137
- Matched controls
- 31366
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1413
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1013
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
325
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
323.0
825
1345
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
2953.5
323.0
729
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
306.0
323.0
377
14
KAC10
NOMESCO Finland
Total nephrectomy with capsule
740.8
323.0
826
15
197
Kela drug reimbursment
Sunitinib
537.6
323.0
338
7
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
4715.2
323.0
2811
53
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
449.0
323.0
621
17
KAD00
NOMESCO Finland
Partial nephrectomy
388.2
323.0
402
12
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
261.3
323.0
1990
207
B01AB10
ATC
tinzaparin; parenteral
8.4
301.3
733
1104
L01XE04
ATC
[U] sunitinib; oral
1010.3
286.9
277
*
130
Kela drug reimbursment
Malignant tumour
6.2
263.3
806
1654
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
33.1
262.4
349
118
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
241.9
921
2411
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.4
226.3
536
748
JN4CD
NOMESCO Finland
Very extensive body CT
9.2
220.6
493
623
JN4BD
NOMESCO Finland
Extensive body CT
4.7
210.0
829
2210
1502
Kela drug reimbursment
Cabozantinib
1020.4
198.1
192
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
197.4
549
960
3012
Kela drug reimbursment
Cabozantinib
975.1
189.6
184
*
KAC00
NOMESCO Finland
Nephrectomy
113.5
186.6
202
19
C64.80
ICD-10 Finland
Wilms tumour
385.1
183.6
183
5
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
183.2
748
2030
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
30.9
176.2
238
83
159
Kela drug reimbursment
Pazopanib
863.0
168.4
164
*
U75
ICPC
Malignant neoplasm of kidney
177.3
161.3
168
10
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
159.7
152
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
14.7
153.1
265
195
7125
FHL
Nephrectomy (extrrafascial)
1559.3
151.2
146
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
144.9
1205
5569
322
Kela drug reimbursment
Sunitinib
670.3
131.5
129
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
129.0
123
*
B01AB05
ATC
enoxaparin; parenteral
2.6
122.4
1310
6852
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.1
119.2
310
478
L01XE11
ATC
[U] pazopanib; oral
599.9
117.9
116
*
8000/3-C64.9
ICD-O-3
Neoplasm, malignant of kidney, NOS
+∞
113.2
108
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
111.1
106
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
106.6
1631
10024
L01EX07
ATC
cabozantinib; oral
535.3
105.3
104
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
102.4
1714
10906
158
Kela drug reimbursment
Everolimus
513.9
101.1
100
*
180
Kela drug reimbursment
Interferon alfa
40.3
98.1
124
32
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.2
91.8
235
351
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
82.2
406
1233
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.2
80.9
268
555
WX402
NOMESCO Finland
General anaesthesia
2.7
79.4
645
2760
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.3
76.0
246
495
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.0
75.0
258
556
168
Kela drug reimbursment
Axitinib
+∞
74.2
71
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
73.2
402
1321
KA3LT
NOMESCO Finland
Njurlesion coagulation
90.0
71.2
79
9
WZC30
NOMESCO Finland
Teaching
2.6
69.2
569
2431
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
16.2
67.5
111
71
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
66.3
755
3819
L01XE10
ATC
[U] everolimus; oral
318.1
62.6
63
*
N02AA05
ATC
oxycodone; systemic
2.4
61.9
645
3108
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
128.5
59.0
63
5
R31
ICD-10 Finland
Unspecified haematuria
2.5
58.1
527
2355
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
578.3
57.8
57
*
343
Kela drug reimbursment
Pazopanib
+∞
57.5
55
*
U14
ICPC
Kidney symptom/complaint
8.6
57.4
128
154
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
56.5
1071
6627
C648
ICD-10 Finland
NA
+∞
56.4
54
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
56.1
2672
22816
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.2
55.9
157
265
L01XE17
ATC
[U] axitinib; oral
+∞
55.4
53
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.4
51.7
197
469
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.8
48.5
100
105
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
47.9
298
1054
UKC02
NOMESCO Finland
Cystoscopy
2.0
47.5
716
4007
C08CA01
ATC
amlodipine; oral
1.8
46.6
1339
9358
L01EX01
ATC
sunitinib; oral
238.4
46.1
47
*
R4110
NOMESCO Finland
Physiotherapy
1.9
45.9
902
5561
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.9
45.6
155
328
8960/3-C64.9
ICD-O-3
Nephroblastoma, NOS, of kidney, NOS
+∞
44.9
43
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
44.4
754
4400
A11CC03
ATC
alfacalcidol; systemic
5.0
44.2
147
304
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
21.4
44.0
65
31
TK800
NOMESCO Finland
Hemodialysis
5.2
44.0
142
284
340
Kela drug reimbursment
Everolimus
433.3
43.3
43
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
42.2
425
1979
Z51.5
ICD-10 Finland
Palliative care
2.8
42.1
299
1150
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.9
41.3
139
291
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
40.0
333
1404
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
39.9
632
3575
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.8
39.9
138
298
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
39.8
393
1810
361
Kela drug reimbursment
Axitinib
+∞
38.6
37
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.5
37.9
79
85
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
19.0
36.6
56
30
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
19.6
35.7
54
28
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
35.5
34
*
M04AA01
ATC
allopurinol; systemic
1.9
34.5
557
3150
205
Kela drug reimbursment
Chronic hypertension
1.6
33.7
1103
7787
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
33.7
259
1039
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
33.4
32
*
V03AE01
ATC
polystyrene sulfonate; oral
6.0
32.6
92
157
198
Kela drug reimbursment
Sorafenib
18.4
31.8
49
27
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.5
31.6
76
104
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
31.3
202
731
ZXA05
NOMESCO Finland
Left side
1.7
30.2
856
5768
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
58.9
30.1
35
6
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
9.4
29.8
62
67
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
5.6
29.7
88
160
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.8
29.6
60
62
A12AA04
ATC
calcium carbonate; oral
5.0
29.4
97
200
BCA30
NOMESCO Finland
Unilateral adrenalectomy
27.0
29.3
40
15
S18
ICPC
Laceration/cut
1.5
28.9
1318
9999
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
28.1
232
970
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
27.9
1965
16406
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
146.2
27.7
29
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.1
27.6
111
279
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.5
27.2
60
72
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.5
27.0
71
111
SPAT1153
SPAT
Removal of sutures
1.6
26.7
1013
7319
C03CA01
ATC
furosemide; systemic
1.5
26.5
1084
7971
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.9
26.3
74
127
N28.1
ICD-10 Finland
Cyst of kidney
4.8
26.2
89
190
8010/3-C64.9
ICD-O-3
Carcinoma, NOS, of kidney, NOS
+∞
26.1
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
25.6
401
2228
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
25.4
530
3242
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
6.0
25.2
70
118
L03AA04
ATC
NA
16.2
24.9
40
25
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.5
24.9
90
205
WX704
NOMESCO Finland
Intubation
2.3
24.8
245
1121
N18.0
ICD-10 Finland
End-stage renal disease
5.3
24.5
76
147
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.8
24.2
52
60
WW500
NOMESCO Finland
Blood transfusion
2.7
24.1
167
630
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
56.4
24.0
28
5
L01EX03
ATC
pazopanib; oral
+∞
24.0
23
*
L01XE05
ATC
[U] sorafenib; oral
17.8
23.9
37
21
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.9
23.8
79
165
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
23.6
185
748
ZXA00
NOMESCO Finland
Right side
1.5
23.0
872
6248
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.8
23.0
78
167
Z90.5
ICD-10 Finland
Acquired absence of kidney
65.4
22.8
26
*
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
120.9
22.6
24
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
22.2
430
2560
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.4
22.0
43
42
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.5
22.0
173
705
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
21.9
21
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
62.9
21.9
25
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
18.5
21.7
33
18
B03XA02
ATC
darbepoetin alfa; parenteral
3.7
21.1
93
255
J01MA02
ATC
ciprofloxacin; systemic
1.5
21.0
1194
9295
L03AB04
ATC
interferon alfa-2a; parenteral
16.7
20.9
33
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
20.7
913
6737
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
22.5
20.4
29
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
20.1
537
3507
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
19.8
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
19.8
177
772
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.0
19.6
37
34
L03AB05
ATC
interferon alfa-2b; parenteral
10.1
19.3
38
38
WX110
NOMESCO Finland
Local anesthesy
1.4
19.2
1800
15309
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
18.9
354
2080
H02AB02
ATC
dexamethasone; systemic
1.9
18.9
315
1779
L01EK01
ATC
axitinib; oral
+∞
18.8
18
*
C02AC05
ATC
moxonidine; oral
2.3
18.6
182
828
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.5
18.5
48
75
M05BX04
ATC
denosumab; parenteral
2.3
17.8
174
790
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
17.7
155
668
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
17.7
195
938
137
Kela drug reimbursment
Uraemia requiring dialysis
5.5
17.3
51
94
KH1AD
NOMESCO Finland
CT of urinary organs
2.7
17.1
119
454
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
25.7
16.9
23
9
H05BX01
ATC
cinacalcet; oral
7.6
16.9
39
52
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
22.0
16.8
24
11
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
16.8
66
165
M907, C6488
ICD-10 Finland
NA
+∞
16.7
16
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
10.4
16.6
32
31
RJ128
NOMESCO Finland
NA
15.1
16.6
27
18
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
16.5
80
239
A02BC02
ATC
pantoprazole; systemic
1.4
16.4
1855
16079
C08CA02
ATC
felodipine; oral
1.7
16.3
338
2045
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.1
16.2
185
905
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.3
15.9
48
92
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.9
15.8
98
349
U79
ICPC
Neoplasm urinary tract unspecified
60.3
15.8
18
*
ZXC96
NOMESCO Finland
Robot assisted procedure
2.7
15.7
111
427
Z94.0
ICD-10 Finland
Kidney transplant status
4.7
15.6
52
111
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.8
15.5
35
45
ZX120
NOMESCO Finland
Intravenous
1.8
15.5
292
1717
V03AE02
ATC
sevelamer; oral
8.0
15.3
34
43
KAC20
NOMESCO Finland
Nephroureterectomy
17.8
15.1
23
13
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
15.0
150
691
Z31.5
ICD-10 Finland
Genetic counselling
2.7
15.0
101
378
196
Kela drug reimbursment
Paricalcitol and cinacalcet
8.5
14.9
32
38
A10BH05
ATC
linagliptin; oral
2.1
14.9
176
873
J01MA12
ATC
levofloxacin; systemic
1.5
14.8
576
4095
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
14.3
402
2645
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.9
485
3362
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.5
13.8
109
449
R4190
NOMESCO Finland
Nutritional therapy
2.7
13.7
94
356
E87.5
ICD-10 Finland
Hyperkalaemia
3.1
13.6
73
237
B05DA
ATC
Isotonic solutions
5.4
13.6
40
75
C08CA13
ATC
lercanidipine; oral
1.6
13.6
415
2787
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
8.3
13.5
29
35
7124
FHL
Nephrectomy (simple
140.5
13.5
14
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.5
13.0
60
174
321
Kela drug reimbursment
Paricalcitol and cinacalcet
6.3
12.7
33
53
WX290
NOMESCO Finland
Other blockade of nerve
1.4
12.7
912
7239
XKD00
NOMESCO Finland
Uroflowmetry
1.4
12.7
599
4413
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
12.5
91
359
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
10.1
12.5
24
24
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
130.5
12.4
13
*
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
130.5
12.4
13
*
B01AB04
ATC
dalteparin; parenteral
2.0
12.4
155
789
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
12.3
184
999
127
Kela drug reimbursment
Transplant complication
3.5
12.2
55
157
A06AD11
ATC
lactulose; oral
1.5
12.1
463
3265
C07AB02
ATC
metoprolol; systemic
1.4
12.1
674
5120
J01DB01
ATC
cefalexin; oral
1.3
12.1
2262
20649
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
12.0
188
1040
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
6.2
12.0
31
50
Z49.2
ICD-10 Finland
Other dialysis
5.0
11.7
36
72
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.5
11.6
33
60
U06
ICPC
Haematuria
2.5
11.6
89
363
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.9
11.5
46
119
JN6AD
NOMESCO Finland
CT of torso and neck
3.7
11.5
49
134
C09AA02
ATC
enalapril; systemic
1.4
11.5
647
4919
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
9.6
11.2
22
23
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
9.6
11.2
22
23
G04CA02
ATC
tamsulosin; oral
1.3
11.2
869
6957
N99.0
ICD-10 Finland
Postprocedural renal failure
17.1
11.2
17
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
11.1
508
3713
E83.50
ICD-10 Finland
Hypercalcemia
3.5
11.1
51
149
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
6.4
11.1
28
44
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.1
11.0
29
48
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
43.4
10.9
13
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.8
10.8
44
116
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.5
10.8
37
83
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
10.8
279
1792
WX892
NOMESCO Finland
Monitored bed care
1.7
10.8
228
1389
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.5
10.7
82
331
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
10.7
804
6396
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
17.9
10.7
16
9
L04AA06
ATC
mycophenolic acid; systemic
3.1
10.6
57
188
B03XA01
ATC
erythropoietin; parenteral
3.8
10.5
43
114
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
9.2
10.5
21
23
M10.9
ICD-10 Finland
Gout, unspecified
1.7
10.4
221
1347
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.6
10.3
74
292
WW200
SPAT
NA
0.5
10.2
74
1481
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.6
10.2
45
128
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
7.5
10.2
23
31
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
10.1
283
1857
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.2
10.1
98
448
JLC10
NOMESCO Finland
Distal pancreatectomy
8.4
10.0
21
25
B05DB
ATC
Hypertonic solutions
5.0
10.0
31
63
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.0
10.0
57
193
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
40.2
10.0
12
*
JAH00
NOMESCO Finland
Laparotomy
2.4
9.9
84
361
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
9.9
118
589
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
7.6
9.9
22
29
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
20.1
9.8
14
7
A04AA01
ATC
ondansetron; systemic, rectal
1.8
9.7
174
1008
B02AA02
ATC
tranexamic acid; systemic
1.6
9.7
269
1759
C09BA02
ATC
enalapril and diuretics; systemic
1.6
9.6
277
1830
WX882
NOMESCO Finland
High dependency care
2.2
9.5
93
429
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.5
457
3367
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
100.3
9.4
10
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
30.1
9.4
12
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
+∞
9.4
9
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.3
899
7399
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.7
9.2
60
224
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
5.0
9.2
28
56
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
9.2
140
770
TK820
NOMESCO Finland
Peritoneal dialysis
5.5
9.2
26
48
WF004
NOMESCO Finland
Palliative radiotherapy
2.4
9.2
73
305
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
5.9
9.0
24
41
N02AA01
ATC
morphine; systemic, rectal
2.9
9.0
52
179
N18
ICD-10 Finland
Chronic kidney disease
3.1
8.9
46
148
N03AX16
ATC
pregabalin; oral
1.3
8.9
598
4658
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
7.4
8.9
20
27
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
24.1
8.9
12
5
105
Kela drug reimbursment
Adrenal cortical hypofunction
10.7
8.8
16
15
N19
ICD-10 Finland
Unspecified kidney failure
2.0
8.8
116
605
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
5.9
8.7
23
39
H03AA01
ATC
levothyroxine sodium; systemic
1.4
8.6
523
4007
A79
ICPC
Malignancy NOS
3.0
8.6
47
158
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.5
1164
9989
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
10.0
8.5
16
16
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
8.5
74
324
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.5
8.4
62
249
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
90.3
8.4
9
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
4.7
8.4
27
58
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
8.4
140
793
XX9XW
NOMESCO Finland
NA
4.2
8.4
30
72
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
12.8
8.4
14
11
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
8.3
8
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
8.3
267
1811
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.2
852
7051
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.1
8.2
43
141
OAB42
NOMESCO Finland
Guidance related to known health problem
5.4
8.1
23
43
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
4.7
8.1
26
56
A10AE04
ATC
insulin glargine; parenteral
1.5
8.1
263
1788
GDA20
NOMESCO Finland
Excision of lesion of lung
10.0
8.0
15
15
N05CF01
ATC
zopiclone; oral
1.3
8.0
887
7405
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.3
8.0
68
295
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
8.0
197
1255
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.2
7.9
18
25
H02AB06
ATC
prednisolone; systemic
1.2
7.9
1253
10913
C07AB07
ATC
bisoprolol; oral
1.2
7.9
1452
12857
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.1
7.9
85
409
R33
ICD-10 Finland
Retention of urine
1.5
7.9
272
1874
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
7.8
7.9
17
22
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.0
7.7
42
142
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.8
7.7
118
654
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.8
7.6
30
79
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.6
76
355
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
18.4
7.6
11
6
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.9
7.6
23
47
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
25.0
7.6
10
*
A04AA02
ATC
granisetron; systemic, transdermal
1.7
7.5
152
918
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
7.5
290
2048
J01CA04
ATC
amoxicillin; systemic
1.2
7.4
2086
19288
7121
FHL
Removal of local change or renal resection (eg cyst)
80.2
7.4
8
*
PC5NT
NOMESCO Finland
Endovascular embolisation for kidney bleeding with radiological guidance
80.2
7.4
8
*
UJF32
NOMESCO Finland
Coloscopy
1.3
7.4
707
5777
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
7.4
245
1673
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
13.4
7.4
12
9
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
7.3
94
487
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.6
7.3
49
190
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
6.2
7.2
18
29
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
7.3
7.2
16
22
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.7
7.1
29
79
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.1
1175
10242
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.1
381
2853
J01EA01
ATC
trimethoprim; systemic
1.3
7.1
582
4658
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
3.0
7.0
37
123
SPAT1254
SPAT
Administration of medicine
1.4
7.0
389
2931
A06AH03
ATC
naloxegol; oral
3.0
7.0
38
129
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
7.0
81
403
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.0
485
3791
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.8
7.0
41
146
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.2
6.9
20
39
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.8
6.9
111
626
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.9
906
7695
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.9
105
581
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
13.8
6.9
11
8
C09CA01
ATC
losartan; oral
1.3
6.9
680
5580
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.8
6.8
27
72
N05BA04
ATC
oxazepam; oral
1.3
6.8
572
4590
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
6.8
174
1118
PC5SC
NOMESCO Finland
Selective angiography of kidney artery with X-ray
6.7
6.8
16
24
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
6.7
6.8
16
24
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
3.4
6.7
30
89
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
6.7
107
601
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.9
6.6
38
132
212
Kela drug reimbursment
Gout
2.0
6.6
74
366
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
7.8
6.6
14
18
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
4.2
6.6
23
55
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.4
6.6
29
85
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
12.3
6.6
11
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.6
200
1340
JAH01
NOMESCO Finland
Laparoscopy
2.0
6.5
82
425
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.5
342
2556
E66.8
ICD-10 Finland
Other obesity
1.9
6.5
92
498
GDB10
NOMESCO Finland
Wedge resection of lung
6.2
6.5
16
26
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.4
130
788
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
70.0
6.4
7
*
1XC17
NOMESCO Finland
NA
70.0
6.4
7
*
D30.1
ICD-10 Finland
Benign neoplasm: Renal pelvis
70.0
6.4
7
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
8.1
6.3
13
16
C03AA03
ATC
hydrochlorothiazide; oral
1.4
6.3
273
1973
TK810
NOMESCO Finland
Hemofiltration
3.7
6.3
25
68
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.2
6
*
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
6.2
6
*
1890C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,MUU/TARK MÄÄR SYÖPÄ]
+∞
6.2
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.2
6
*
1899X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]
+∞
6.2
6
*
KAC96
NOMESCO Finland
Other nephrectomy
+∞
6.2
6
*
KAD10
NOMESCO Finland
Heminephrectomy
+∞
6.2
6
*
C68
ICD-10 Finland
Malignant neoplasm of other and unspecified urinary organs
+∞
6.2
6
*
H02AB09
ATC
hydrocortisone; systemic
2.2
6.2
60
280
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
6.2
690
5736
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.2
216
1494
R04.2
ICD-10 Finland
Haemoptysis
1.8
6.2
99
560
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.0
6.1
22
55
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037121) Protein [Mass/volume] in Urine
522
1018
5.87
260.54
3.0
3.1
g/l
0.3
0.3
0.13
351
413
(3020779) Urea [Moles/volume] in Serum or Plasma
802
2986
3.20
162.72
9.4
6.9
mmol/l
11.6
10.8
2.28
761
2821
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2089
13026
2.56
149.95
5.1
4.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
548
1772
3.49
138.23
7.7
9.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2030
12873
2.42
134.50
8.1
4.9
g/l
34.2
34.8
3.81
1917
11917
(3002173) Hemoglobin [Mass/volume] in Arterial blood
770
3115
2.90
132.21
7.4
8.0
g/l
120.0
120.9
0.70
753
2988
(3016502) Oxygen saturation in Arterial blood
818
3429
2.82
131.28
7.0
7.5
%
96.6
95.4
8.22
790
3292
(4035726)
661
2479
3.07
129.90
1.3
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
919
4118
2.69
129.26
9.2
5.8
mmol/l
1.1
1.0
5.77
865
3814
(3044640) Blood type and Crossmatch panel - Blood
1558
9038
2.33
123.41
3.0
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2069
13538
2.34
123.02
10.4
6.2
mmol/l
1.2
1.2
0.11
1955
12209
(3003396) Base excess in Arterial blood by calculation
854
3795
2.67
121.19
7.0
7.2
mmol/l
-0.2
1.1
17.71
685
2937
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
852
3802
2.65
119.72
7.0
7.2
kpa
5.3
5.1
7.51
823
3610
(3027801) Oxygen [Partial pressure] in Arterial blood
851
3802
2.65
119.23
7.0
7.2
kpa
13.6
12.0
13.80
821
3610
(3000991) Gas panel - Venous blood
676
2696
2.88
117.98
9.2
8.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1542
9207
2.23
110.47
4.8
3.5
e6/l
83.7
84.1
0.01
1328
7205
(3014576) Chloride [Moles/volume] in Serum or Plasma
872
4085
2.52
109.59
8.4
6.8
mmol/l
104.8
104.4
2.23
860
3971
(3031040) Bacteria [#/volume] in Urine by Automated count
2519
18399
2.41
109.29
6.1
4.8
e6/l
621.8
1556.6
0.86
35
318
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
821
3747
2.57
108.95
4.4
4.2
u/l
236.3
245.1
0.87
800
3522
(3030467) Casts [#/volume] in Urine by Automated count
1431
8394
2.21
105.97
4.6
3.3
e6/l
0.3
0.5
1.22
1220
6426
(3000850) Epithelial cells [#/volume] in Urine
1187
6485
2.27
104.35
3.5
2.7
e6/l
3.5
4.7
4.55
1077
5693
(36304419) Bacteria [Presence] in Urine
1381
8075
2.19
102.15
4.5
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2131
14895
2.15
97.23
12.2
7.0
mmol/l
1.2
1.2
0.53
1800
12544
(3018095) Leukocytes [#/volume] in Urine
1626
10378
2.08
93.20
5.5
3.9
e6/l
68.7
117.1
2.02
1369
7645
(3035637) Corticotropin [Mass/volume] in Plasma
177
322
5.74
93.17
1.6
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
1103
6072
2.21
93.15
4.0
2.9
mosm/kgh2o
540.7
559.6
2.54
985
5167
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2119
15025
2.08
89.78
11.8
6.3
umol/l
10.8
12.4
5.51
2042
14259
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
465
1751
2.92
88.57
8.1
9.2
mmol/l
23.4
24.3
10.79
449
1624
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2728
21592
2.31
83.15
14.6
7.7
u/l
82.4
80.8
1.11
2651
20268
(40768804) Tissue Pathology biopsy report
1629
10708
2.00
82.87
2.5
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1188
6985
2.07
82.55
2.9
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1868
12961
1.97
80.34
11.2
10.7
inr
1.2
1.3
6.95
521
3537
(3023368) Bacteria identified in Blood by Culture
1412
8942
1.99
78.82
5.3
4.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
617
2850
2.42
77.16
7.5
6.8
mmol/l
1.2
1.4
11.35
600
2739
(3013826) Glucose [Moles/volume] in Serum or Plasma
2293
17220
2.01
76.71
7.0
5.0
mmol/l
6.9
6.9
0.11
2220
16246
(3018418) pH of Serum or Plasma
1386
8824
1.96
75.26
7.5
4.1
ph
7.4
7.4
5.39
310
1674
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
523
2287
2.52
73.42
6.1
3.9
ng/l
134.8
97.6
8.20
465
1948
(3012095) Magnesium [Moles/volume] in Serum or Plasma
897
4952
2.10
72.14
4.6
3.2
mmol/l
0.8
0.8
0.30
855
4611
(3037467) Urinalysis macro (dipstick) panel - Urine
2438
18971
2.00
70.19
6.2
4.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2114
15831
1.88
66.49
14.2
8.8
e9/l
4.3
4.3
0.46
1878
13725
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
867
4876
2.04
65.38
4.2
3.1
e6/l
1.8
1.7
0.13
549
2745
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
903
5180
2.01
64.27
3.9
2.9
e6/l
0.8
1.2
3.29
583
3026
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1361
8973
1.86
63.49
4.2
2.6
u/l
66.0
59.3
1.44
1281
8248
(3015377) Calcium [Moles/volume] in Serum or Plasma
1446
9771
1.83
61.85
6.7
3.4
mmol/l
2.4
2.3
2.90
1306
8386
(3026008) Bacteria identified in Urine by Culture
1326
8829
1.82
58.69
3.4
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
494
2356
2.28
56.11
5.2
2.2
nmol/l
393.5
372.0
1.59
474
2142
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
739
4252
1.94
50.50
4.1
2.6
%
20.3
22.5
4.33
629
3617
(3033658) Prothrombin time (PT) actual/Normal
1111
7265
1.78
50.45
5.4
4.1
%
91.2
84.6
13.71
1093
7100
(3004789) Transferrin [Mass/volume] in Serum or Plasma
769
4508
1.91
49.57
4.0
2.5
g/l
2.1
2.3
13.48
723
4176
(3022948) Iron [Moles/volume] in Serum or Plasma
809
4829
1.88
49.29
3.9
2.5
umol/l
10.8
12.6
10.89
758
4476
(3018677) aPTT in Platelet poor plasma by Coagulation assay
817
4935
1.86
47.74
2.2
2.0
s
30.0
30.1
0.38
810
4780
(3009214) Lutropin [Units/volume] in Serum or Plasma
160
469
3.53
45.73
1.5
1.4
u/l
16.2
8.7
4.59
123
377
(3049717) Cytology report of Urine Cyto stain
328
1429
2.43
45.40
2.4
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
887
5584
1.79
44.87
6.1
3.1
mmol/l
2.5
2.5
5.93
807
4871
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
213
766
2.90
43.27
4.9
3.3
mg/l
1.8
1.7
2.34
194
689
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
286
1196
2.52
43.19
2.8
2.7
u/ml
0.4
0.3
0.71
135
686
(42870588) Differential panel, method unspecified - Blood
1328
9631
1.62
38.34
6.9
5.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
324
1542
2.22
36.27
7.2
3.9
mmol/l
23.6
24.1
2.31
300
1378
(3019060) Gas panel - Arterial blood
425
2245
2.02
36.20
5.1
4.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1741
13616
1.57
35.51
6.8
5.7
e9/l
0.0
0.0
0.40
1512
11621
(3001604) Monocytes [#/volume] in Blood
1733
13543
1.57
35.44
6.8
5.7
e9/l
0.6
0.6
0.53
1500
11543
(3019198) Lymphocytes [#/volume] in Blood
1763
13850
1.56
35.09
7.0
5.8
e9/l
1.9
1.9
0.14
1546
12021
(3002032) Base excess in Venous blood by calculation
533
3077
1.87
34.80
6.5
3.7
mmol/l
1.2
2.0
4.53
436
2459
(3013115) Eosinophils [#/volume] in Blood
1782
14059
1.56
34.61
7.1
5.9
e9/l
0.2
0.2
0.80
1561
12172
(3008152) Bicarbonate [Moles/volume] in Arterial blood
399
2099
2.02
34.29
7.2
6.9
mmol/l
24.2
24.5
0.60
378
1950
(3022096) Basophils/100 leukocytes in Blood
1608
12435
1.55
33.89
7.1
6.1
%
0.6
0.7
1.19
1523
11527
(3019069) Monocytes/100 leukocytes in Blood
1649
12825
1.55
33.86
7.4
6.3
%
8.7
9.0
2.35
1561
11915
(3002030) Lymphocytes/100 leukocytes in Blood
1671
13062
1.55
33.34
7.2
6.2
%
25.0
26.3
4.69
1570
12056
(3021447) Carbon dioxide [Partial pressure] in Venous blood
529
3086
1.84
33.30
6.3
3.7
kpa
5.9
5.8
0.40
516
2985
(3002256) Pathology report gross observation
599
3632
1.79
33.18
1.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
544
3211
1.83
32.94
6.2
3.7
ph
7.4
7.4
—
7
17
(3006504) Eosinophils/100 leukocytes in Blood
1637
12773
1.54
32.70
7.1
6.0
%
2.9
2.9
0.28
1550
11823
(3026493) Urate [Moles/volume] in Serum or Plasma
1097
7832
1.59
32.47
3.7
2.9
umol/l
2785.6
5925.6
1.91
952
6672
(3035350) Ketones [Presence] in Urine by Test strip
1687
13289
1.53
31.99
5.1
3.8
estimate
0.0
0.0
0.50
400
2451
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1173
8551
1.57
31.51
4.7
3.2
u/l
31.8
39.1
2.25
1121
8091
(3018010) Neutrophils/100 leukocytes in Blood
1639
12861
1.53
31.44
7.0
6.0
%
59.7
58.3
4.97
1550
11935
(3018572) Chloride [Moles/volume] in Blood
185
735
2.60
30.95
6.4
7.3
mmol/l
105.8
105.4
0.94
169
651
(3039000) Anion gap in Blood
185
735
2.60
30.95
6.4
7.3
mmol/l
11.3
11.3
0.01
169
651
(3009261) Glucose [Presence] in Urine by Test strip
1695
13454
1.52
30.42
5.2
3.9
estimate
0.0
0.0
0.20
400
2380
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
102
301
3.46
28.88
1.5
1.3
nmol/l
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1667
13285
1.50
28.69
6.8
5.1
estimate
0.0
0.0
0.00
408
2480
(3047181) Lactate [Moles/volume] in Blood
222
1005
2.29
27.90
6.0
6.5
mmol/l
1.2
1.3
1.68
199
882
(1616796) Gas panel - Central venous blood
179
737
2.51
27.80
4.5
4.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
108
343
3.22
27.21
1.6
1.3
nmol/l
0.7
0.7
0.07
103
325
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
100
312
3.27
25.95
1.7
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
374
3.06
25.95
1.7
1.4
iu/l
34.4
30.5
0.44
78
309
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
764
5242
1.59
25.75
1.9
1.9
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
106
346
3.13
25.53
1.6
1.3
nmol/l
0.2
0.3
0.57
11
25
(3020630) Protein [Mass/volume] in Serum or Plasma
462
2796
1.75
25.25
3.0
2.6
g/l
65.6
66.1
0.64
429
2538
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
385
2235
1.81
24.19
1.8
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
945
6888
1.51
23.99
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1236
9527
1.47
23.71
3.7
3.2
mmol/l
7.1
7.5
2.99
1018
7914
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
406
2409
1.78
23.68
2.1
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
950
6950
1.51
23.64
10.6
6.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2309
20045
1.47
23.25
5.0
4.1
mm/h
18.6
13.6
22.24
2131
18389
(3017143) Hepatitis C virus Ab [Presence] in Serum
388
2292
1.78
22.95
2.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
503
3196
1.67
22.87
4.1
3.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
48
98
4.95
22.26
1.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1202
9312
1.45
22.03
3.8
3.3
mg/l
609.8
285.7
1.48
818
6052
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
123
475
2.65
21.82
5.1
3.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
59
145
4.12
21.76
1.3
1.3
u/l
37.1
28.5
0.86
54
114
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
495
3192
1.64
21.13
3.1
2.8
umol/l
8.0
9.6
1.01
439
2811
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1287
10169
1.43
20.89
5.6
4.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1248
9830
1.42
20.51
4.6
4.0
mg/mmol
24.6
8.8
10.33
835
6349
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
505
3318
1.61
19.91
3.0
4.1
ug/l
8.1
22.6
2.19
405
2753
(3012501) Base excess in Blood by calculation
159
723
2.26
19.78
5.2
5.0
mmol/l
2.4
2.6
0.29
107
493
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
33
53
6.28
19.72
10.9
2.3
u/l
56.2
46.8
0.42
19
14
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
340
2021
1.76
19.58
5.0
3.7
mmol/l
1.0
1.9
3.56
243
1469
(3009343) pH of Capillary blood
346
2095
1.72
18.64
5.0
3.8
ph
7.4
7.4
0.67
60
257
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
238
1298
1.90
18.13
4.5
3.1
pmol/l
4.2
4.4
1.00
213
1124
(40761536) Microorganisms panel - Urine sediment
368
2285
1.68
18.05
5.5
4.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1324
10712
1.39
17.93
3.7
2.8
ug/l
219.3
164.3
5.95
1199
9725
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
347
2125
1.70
17.91
5.1
3.8
kpa
5.1
5.1
0.06
326
1960
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
250
1392
1.86
17.85
5.7
5.3
%
1.7
1.6
1.17
232
1302
(3041096) Erythrocytes [Presence] in Urine by Automated
913
6936
1.43
17.79
4.9
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
392
2484
1.65
17.77
7.4
3.9
mmol/l
1.2
1.2
0.40
365
2169
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
534
3651
1.55
17.59
1.8
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
436
2848
1.61
17.48
2.1
2.2
g/l
0.2
0.2
2.70
409
2646
(3007930) Methemoglobin/Hemoglobin.total in Blood
246
1372
1.85
17.47
5.8
5.3
%
1.0
0.9
3.43
229
1283
(3027945) Reticulocytes/100 erythrocytes in Blood
562
3891
1.53
17.47
2.7
2.5
%
1.8
1.8
0.24
511
3416
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
126
551
2.34
17.20
4.0
5.5
iu/ml
834.9
3289.7
0.44
14
83
(3029937) Albumin [Presence] in Urine by Test strip
952
7326
1.42
17.14
5.7
4.2
estimate
0.0
0.0
0.52
371
2324
(3024354) Oxygen [Partial pressure] in Venous blood
396
2542
1.63
17.03
4.7
3.0
kpa
4.8
4.5
1.63
383
2452
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
216
1169
1.90
16.84
2.8
3.3
u/ml
12820.9
2289.2
0.43
188
1010
(3011985) Renin [Units/volume] in Plasma
90
339
2.70
16.83
1.7
1.4
mu/l
42.8
71.0
0.75
78
297
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
529
3649
1.53
16.67
1.8
1.8
—
—
—
0
0
(3010421) pH of Blood
169
846
2.05
16.49
5.2
4.6
ph
7.4
7.4
2.47
158
711
(46235355) HIV 1 and 2 tests - Meaningful Use set
426
2828
1.58
15.88
2.0
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
399
2617
1.59
15.65
3.1
2.4
u/l
68.8
38.3
0.47
360
2228
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
140
667
2.15
15.57
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
270
1607
1.74
15.41
1.6
1.7
g/l
1.8
1.5
3.80
225
1372
(3042936) Bacteria identified in Isolate by Culture
595
4271
1.48
15.37
2.1
2.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
113
505
2.28
14.71
1.5
1.8
iu/l
2.4
4.5
3.42
29
158
(3023199) Leukocytes [#/volume] in Pleural fluid
105
455
2.35
14.68
1.4
1.5
e6/l
1572.8
1869.9
0.34
71
328
(3052851) Hemolysis interference index of Serum or Plasma
171
898
1.95
14.60
3.8
3.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
973
7691
1.37
14.46
2.3
2.3
mg/l
3.3
3.0
2.87
833
6504
(3003434) Protein [Mass/volume] in Pleural fluid
113
516
2.23
13.99
1.4
1.5
g/l
32.9
31.6
0.48
101
463
(3023520) Reticulocytes [#/volume] in Blood
430
2945
1.53
13.86
3.0
2.5
e9/l
66.3
68.6
0.72
326
2256
(40761535) Cells panel - Urine sediment
379
2538
1.55
13.52
4.5
3.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
17
20
8.54
13.25
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
350
2330
1.56
12.80
2.0
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
238
1442
1.70
12.73
2.0
2.0
ug/l
1.5
2.4
0.86
215
1262
(3022313) Gas panel - Capillary blood
248
1524
1.68
12.59
5.1
3.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
138
711
1.98
12.49
3.2
2.5
%
16.7
16.0
0.93
80
370
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
350
2349
1.55
12.33
4.2
2.8
ml/min/173m2
48.3
61.8
17.11
224
986
(3021589) Normoblasts [#/volume] in Blood
1404
11921
1.30
12.23
16.0
10.3
e9/l
0.0
0.0
0.91
1151
9717
(3028308) Erythrocytes [#/volume] in Pleural fluid
93
415
2.28
12.21
1.3
1.4
e6/l
82051.7
81312.6
0.01
50
258
(3012441) Differential panel - Pleural fluid
91
403
2.29
12.16
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
84
363
2.35
11.88
1.4
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
185
1080
1.75
11.33
2.4
3.4
ratio
1.5
2.4
0.64
12
76
(3021901) Oxygen saturation in Capillary blood
128
667
1.95
11.24
3.4
2.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
150
824
1.86
11.23
3.4
3.3
kpa
8.3
8.0
0.94
143
764
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
742
5815
1.35
11.20
1.7
1.7
mg/l
1.6
1.5
0.51
601
4533
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1371
11709
1.29
11.07
4.7
4.0
ng/l
46.3
58.6
0.80
1115
8944
(3021879) Hepatitis B virus core Ab [Presence] in Serum
234
1465
1.64
11.06
1.4
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
39
117
3.36
10.94
26.0
28.9
ug/l
83.6
119.4
5.02
33
102
(3024928) Oxygen saturation in Venous blood
131
695
1.92
10.92
3.8
2.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2830
26586
1.38
10.86
26.9
16.7
mg/l
35.0
26.7
24.73
2624
21632
(3034860) Kappa light chains.free [Mass/volume] in Serum
187
1110
1.72
10.80
2.4
3.4
mg/l
60.8
108.7
0.45
153
896
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
74
316
2.37
10.79
1.3
1.4
pmol/l
226.3
273.2
0.92
62
238
(3016750) Collection duration of Urine
52
187
2.81
10.74
1.8
2.0
min
494.3
488.0
0.19
41
131
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
186
1109
1.72
10.58
2.4
3.4
mg/l
82.9
66.3
0.23
151
900
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
145
805
1.84
10.52
2.2
2.4
g/l
4.0
3.6
1.45
140
762
(40768806) Pleura Pathology biopsy report
87
404
2.18
10.43
1.4
1.6
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
18
30
6.03
10.38
4.6
5.7
ug/min
59.7
52.5
0.17
18
24
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
198
1211
1.67
10.25
1.3
1.2
iu/ml
159.9
136.2
0.29
59
416
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1271
10831
1.28
10.21
2.7
2.2
nmol/l
79.9
78.4
0.91
1147
9489
(3011397) Hemoglobin [Presence] in Urine by Test strip
804
6461
1.32
10.09
4.8
3.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
77
346
2.25
10.01
1.5
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
165
972
1.73
9.82
1.3
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
168
997
1.72
9.74
4.9
4.0
mmol/l
4.0
3.9
1.78
159
921
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
36
5.30
9.63
4.3
5.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
30
83
3.64
9.53
1.9
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
155
905
1.75
9.53
2.0
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
204
1282
1.63
9.52
5.8
4.1
mmol/l
24.1
24.8
2.45
192
1179
(3007853) Bacteria identified in Skin by Aerobe culture
453
3380
1.39
9.16
1.9
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
152
893
1.73
9.15
3.8
3.3
mmol/l
23.6
25.0
3.91
140
771
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
105
550
1.94
9.15
1.2
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
128
718
1.81
9.03
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
130
734
1.80
8.97
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
131
746
1.79
8.80
1.3
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
173
2.68
8.79
1.8
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
690
5523
1.31
8.76
5.2
4.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
68
309
2.22
8.66
3.8
2.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
32
99
3.25
8.61
1.8
2.1
—
—
—
0
0
(3020891) Body temperature
204
1315
1.59
8.59
6.2
4.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
287
1999
1.48
8.45
1.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
181
1140
1.62
8.40
2.4
2.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
139
821
1.72
8.24
2.6
2.3
ug/min
201.0
86.2
1.78
86
494
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
61
271
2.27
8.21
1.2
1.3
u/l
17.0
13.9
0.29
54
252
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
275
1912
1.48
8.18
1.6
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
46
180
2.58
8.16
1.8
2.1
%
18.4
15.2
0.32
14
76
(3025315) Body weight
13
20
6.52
8.06
6.2
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
98
525
1.89
8.03
3.7
3.4
%
59.9
58.6
0.46
98
525
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2102
19277
1.24
7.97
6.6
3.7
pmol/l
15.2
15.0
2.85
1920
17188
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
124
719
1.75
7.86
2.2
2.4
%
220.9
201.5
1.41
119
689
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1145
9869
1.24
7.78
3.2
3.1
ng/l
2365.7
1707.2
2.94
1025
8576
(3006184) Hemoglobin [Mass/volume] in Capillary blood
125
729
1.74
7.77
3.1
2.1
g/l
129.7
127.9
0.29
102
535
(3051651) Icteric interference index of Serum or Plasma
43
171
2.53
7.41
4.6
3.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
226
1542
1.50
7.39
4.0
2.5
%
1.2
1.2
0.03
226
1532
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1066
9165
1.24
7.31
2.2
2.2
u/l
202.4
229.8
0.44
1002
8541
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
36
132
2.75
7.27
8.1
5.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
131
790
1.68
7.24
2.1
2.2
%
90.4
88.4
0.48
125
758
(3019225) pH of Specimen
403
3064
1.36
7.21
8.3
4.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
137
843
1.65
7.02
2.3
3.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
83
442
1.90
6.97
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
93
518
1.82
6.80
1.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
739
6150
1.26
6.71
4.7
4.0
ng/l
1447.6
428.0
0.42
640
5236
(3004775) Volume in Urine collected for unspecified duration
57
269
2.14
6.69
1.9
2.2
ml
694.5
629.6
0.60
42
164
(3011412) CD3 cells [#/volume] in Blood
53
245
2.18
6.56
1.7
2.2
e9/l
1.0
1.1
0.35
39
144
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
23
69
3.35
6.54
1.2
1.0
pmol/l
393.6
260.0
0.45
15
48
(3027273) Bicarbonate [Moles/volume] in Venous blood
232
1632
1.45
6.53
5.4
3.3
mmol/l
24.2
25.1
3.80
227
1584
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
172
1139
1.54
6.50
2.3
2.2
ug/l
491.4
684.3
0.40
166
1076
(3019150) Specific gravity of Urine by Refractometry
714
5943
1.25
6.44
5.9
4.3
kg/l
1.0
1.0
0.03
121
914
(3044889) 12 lead EKG panel
2120
19656
1.21
6.42
4.9
4.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
133
833
1.62
6.39
1.4
1.5
ug/g
249.4
268.8
0.54
82
508
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1316
1.49
6.37
1.8
2.4
g/l
4.0
3.8
0.50
134
949
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1317
1.49
6.34
1.8
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1318
1.49
6.32
1.8
2.4
g/l
7.8
7.4
1.53
138
984
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
68
351
1.96
6.30
1.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
130
813
1.62
6.29
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
77
415
1.87
6.28
1.3
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
181
1223
1.51
6.24
1.8
2.5
g/l
3.4
3.1
2.27
137
967
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
88
496
1.79
6.22
2.0
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
83
463
1.81
6.08
1.3
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
42
182
2.32
6.08
6.9
5.0
u/ml
30.1
41.0
0.20
12
47
(3013512) EKG study
1021
8875
1.21
6.07
4.8
4.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1793
16416
1.19
6.06
3.5
3.2
u/l
62.0
56.9
1.26
1642
15002
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
79
435
1.84
6.04
2.0
1.4
u/ml
113.2
119.8
0.23
25
82
(3033923) Metanephrine [Moles/time] in 24 hour Urine
19
54
3.53
5.87
1.0
1.1
umol/24h
0.7
0.7
—
10
30
(3036489) Thrombin time
152
1003
1.54
5.87
2.0
2.0
s
23.1
21.6
1.09
139
911
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
38
160
2.39
5.87
2.2
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
17
45
3.79
5.81
1.8
1.8
ug/l
1.4
3.2
1.12
12
27
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
53
258
2.07
5.80
1.2
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
109
667
1.65
5.77
1.7
2.8
umol/l
28.2
36.0
2.94
77
555
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
180
1238
1.48
5.72
1.8
2.4
g/l
10.9
10.3
0.73
146
1048
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
78
437
1.80
5.66
1.2
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
94
562
1.69
5.46
1.5
1.3
mmol/l
53.2
63.0
2.16
78
447
(3051611) Lipemic interference index of Serum or Plasma
58
300
1.95
5.39
4.2
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
416
1.80
5.33
1.2
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
18
53
3.41
5.30
2.0
1.7
ng/l
185.2
163.9
0.19
18
53
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
54
275
1.98
5.26
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
76
433
1.77
5.24
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
53
270
1.98
5.16
1.2
1.2
u/l
71.8
60.1
0.27
37
191
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
115
2.53
5.12
1.3
4.3
mg/l
65.0
61.2
0.12
21
81
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
175
1227
1.45
5.07
2.1
1.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
162
1123
1.46
4.99
2.0
2.5
g/l
1.4
1.1
0.34
143
965
(40768797) Stomach Pathology biopsy report
472
3860
1.26
4.89
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
313
2435
1.31
4.80
4.2
4.1
%
0.7
0.9
0.65
121
735
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
59
320
1.86
4.80
1.4
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
187
1342
1.42
4.79
1.3
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
844
7353
1.20
4.71
1.7
1.6
nmol/l
18.8
20.1
1.56
747
6213
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
184
1329
1.41
4.56
2.1
2.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
283
2197
1.31
4.42
4.1
3.9
%
0.6
0.6
0.25
87
515
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
23
88
2.62
4.39
1.5
1.3
%
27.7
25.0
0.15
23
68
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
35
163
2.16
4.36
1.6
1.7
u/l
4.0
6.8
0.65
22
82
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
135
931
1.47
4.31
3.7
3.8
u/ml
45.9
76.8
1.48
127
895
(3035880) pH of Pleural fluid
42
211
2.00
4.31
1.3
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
22
4.56
4.30
2.3
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
73
437
1.68
4.30
6.5
6.6
mg/l
11.9
12.3
0.27
67
408
(3037756) Immunofixation for Serum or Plasma
112
744
1.52
4.29
1.2
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
24
95
2.54
4.29
2.8
2.7
mu/l
16.4
19.5
0.43
24
89
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
44
226
1.96
4.25
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
93
595
1.58
4.21
1.6
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
159
2.15
4.21
2.0
1.5
u/field
2.0
3.8
0.61
23
115
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
141
987
1.45
4.18
1.7
2.4
g/l
0.0
0.0
0.44
132
901
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
109
2.40
4.14
2.3
2.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
293
2308
1.29
4.13
4.3
4.1
%
0.1
0.1
0.25
114
679
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
106
703
1.52
4.11
2.9
3.4
u/ml
32.0
923.7
1.56
95
650
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
94
609
1.56
4.05
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2251
21347
1.16
4.02
35.4
20.4
%
14.2
13.8
24.86
2218
20836
(3008757) Leukocyte morphology finding [Identifier] in Blood
60
347
1.74
4.02
3.7
4.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
275
2157
1.30
4.01
4.4
4.1
%
0.1
0.3
0.50
99
563
(3004809) Band form neutrophils/100 leukocytes in Blood
84
533
1.59
3.96
3.8
3.7
%
1.1
1.7
1.42
72
399
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
133
931
1.45
3.96
1.7
2.4
g/l
0.0
0.0
0.00
125
848
(21494755) Public health laboratory ask at order entry panel
87
1326
0.65
3.95
1.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
131
916
1.45
3.93
1.6
2.4
g/l
0.0
0.0
0.00
125
847
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
145
1036
1.42
3.87
1.8
2.3
g/l
36.1
37.4
1.67
128
888
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
137
971
1.43
3.83
1.5
1.5
titre
117.8
231.2
—
9
48
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
53
301
1.77
3.79
1.4
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
35
174
2.02
3.73
1.6
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
36
181
2.00
3.73
1.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
73
455
1.62
3.73
1.4
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
142
2.12
3.64
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
19
73
2.61
3.63
7.1
4.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
88
578
1.54
3.61
1.6
1.2
u/l
65.4
47.6
0.28
76
501
(1761868) Lipid panel - Serum or Plasma
706
8012
0.85
3.60
3.3
3.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
73
462
1.59
3.52
2.1
2.8
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
57
2.82
3.52
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
151
2.06
3.51
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
34
174
1.96
3.38
1.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
34
174
1.96
3.38
1.3
1.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
24
107
2.25
3.38
1.2
1.2
ug/l
238.5
484.8
—
8
50
(3036603) Volume of Urine
35
182
1.93
3.33
1.7
1.6
ml
1739.6
1799.7
—
9
46
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
101
696
1.46
3.32
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
101
696
1.46
3.32
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
59
938
0.62
3.30
1.8
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
77
2.48
3.29
1.7
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2572
26609
0.86
3.29
5.3
5.3
mmol/l
2.5
2.6
4.51
2303
24111
(40761511) CBC panel - Blood by Automated count
2807
27223
1.17
3.21
27.6
15.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
363
3024
1.22
3.20
1.4
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
55
2.73
3.15
1.1
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2882
28029
1.18
3.09
34.7
19.8
mmol/l
139.0
139.6
28.60
2838
27291
(3017732) Neutrophils [#/volume] in Blood
225
1784
1.28
3.07
4.2
3.4
e9/l
4.5
4.2
0.55
174
1306
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
8
16
5.01
3.05
4.5
3.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
92
636
1.46
3.01
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
243
1.74
2.90
1.5
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
109
784
1.40
2.89
1.2
1.3
—
16.2
—
0
18
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
110
1505
0.72
2.88
2.1
1.8
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
58
2.59
2.87
1.2
1.2
mmol/l
0.8
2.4
—
10
42
(3024471) HLA-A [Type]
19
83
2.30
2.83
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
89
620
1.45
2.82
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
70
465
1.52
2.80
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1436
13411
1.12
2.78
2.6
2.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2883
28090
1.17
2.78
35.1
20.0
mmol/l
4.1
4.0
55.89
2836
27311
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
10
31
3.23
2.77
1.1
1.1
umol/24h
2.0
1.8
—
10
31
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
103
741
1.40
2.74
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
37
210
1.77
2.74
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2470
23820
1.13
2.72
7.3
4.5
mu/l
2.2
2.1
0.82
2272
21346
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
248
1.70
2.72
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
27
139
1.95
2.69
1.4
1.5
nmol/l
0.2
0.2
0.09
21
108
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
18
79
2.29
2.67
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
79
2.29
2.67
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2512
25925
0.88
2.64
4.9
4.7
mmol/l
4.4
4.5
4.01
2272
23634
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1337
12462
1.12
2.64
2.1
2.1
pmol/l
93.9
92.8
0.34
740
6574
(3048929) Epstein Barr virus Ab [Presence] in Serum
85
596
1.44
2.62
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
65
432
1.51
2.62
1.4
1.2
u/ml
257.4
295.0
0.52
43
252
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
206
1.76
2.61
1.3
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
18
80
2.26
2.60
1.9
2.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
15
4.67
2.59
5.3
3.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
60
393
1.54
2.58
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
103
750
1.38
2.58
1.2
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
9
25
3.61
2.57
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
30
164
1.84
2.53
1.2
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
143
1.90
2.50
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
143
1.90
2.50
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
103
755
1.38
2.49
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
26
3.47
2.48
1.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
28
151
1.86
2.46
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
28
151
1.86
2.46
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2492
25698
0.89
2.46
4.8
4.7
mmol/l
1.3
1.4
24.45
2239
23232
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
29
159
1.83
2.43
1.2
1.3
u/l
36.3
18.0
1.15
24
135
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
59
392
1.51
2.40
2.4
2.2
mg/l
15.2
24.2
1.51
16
87
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
6
12
5.01
2.40
9.3
5.0
umol/l
469.7
366.8
—
6
12
(3045414) Leukocytes [Presence] in Urine
161
1267
1.28
2.40
2.2
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
212
1.71
2.39
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
244
2019
1.22
2.36
2.6
2.7
g/l
10.7
10.6
0.07
219
1837
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
147
1.84
2.32
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
47
300
1.57
2.30
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
41
254
1.62
2.27
1.3
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
18
3.89
2.25
3.1
2.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
18
3.89
2.25
6.3
5.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
26
142
1.84
2.23
1.6
1.2
—
—
—
0
0
(44790049)
52
343
1.52
2.22
1.5
1.5
—
—
—
0
0
(44790047)
52
343
1.52
2.22
1.5
1.5
—
—
—
0
0
(44790048)
52
343
1.52
2.22
1.5
1.5
—
—
—
0
0
(44806118)
52
343
1.52
2.22
1.5
1.5
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
9
5.56
2.21
1.6
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
157
1.79
2.21
1.4
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
28
157
1.79
2.21
1.2
1.3
nmol/l
1.4
1.0
0.44
19
116
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2534
26058
0.89
2.21
5.7
5.0
mmol/l
6.2
6.1
2.23
2273
23315
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
54
360
1.51
2.19
1.5
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
26
143
1.82
2.18
1.6
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
46
297
1.56
2.16
1.7
2.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
48
313
1.54
2.16
1.3
1.3
mosm/kgh2o
275.5
277.1
0.13
36
229
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
53
354
1.50
2.14
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
62
428
1.46
2.13
2.1
2.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
387
1.48
2.13
2.9
2.4
u/ml
24.8
819.5
0.62
57
378
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
27
153
1.77
2.07
1.4
1.5
%
61.4
66.6
0.32
22
121
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
20
3.50
2.05
2.0
4.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
53
358
1.49
2.04
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
57
391
1.47
2.04
1.4
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
55
375
1.47
2.03
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
53
359
1.48
2.02
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
216
1.63
2.00
2.1
2.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
209
1.63
1.97
1.3
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
31
186
1.67
1.97
1.7
2.2
e6/l
838.9
645.0
—
9
80
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
108
832
1.31
1.95
1.4
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
34
210
1.63
1.94
1.1
1.1
mmol/l
35.1
34.5
0.04
29
180
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
41
266
1.55
1.92
2.6
1.9
u/field
3.8
2.1
0.68
19
96
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
65
2.16
1.88
1.1
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
55
382
1.45
1.87
3.5
7.1
mmol/l
7.0
7.6
0.64
43
318
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
347
3031
1.16
1.87
2.7
2.4
ug/l
5.3
7.4
1.69
305
2644
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2421
24884
0.91
1.85
4.3
4.2
mmol/l
1.5
1.3
24.13
2151
22307
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
33
205
1.62
1.85
1.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
28
167
1.68
1.83
3.1
2.6
%
27.9
36.5
—
8
62
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
351
1.46
1.83
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
51
351
1.46
1.83
1.5
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
80
2.00
1.79
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
51
353
1.45
1.78
1.5
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
700
0.70
1.77
1.4
1.7
mg/l
6.0
3.8
0.59
40
508
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
171
1.64
1.70
2.7
1.8
u/l
132.0
2549.6
—
6
56
(3045424) Erythrocytes [Presence] in Urine
63
458
1.38
1.69
1.7
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
75
2.00
1.69
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
356
3142
1.15
1.69
1.2
1.3
titre
455.8
505.2
0.17
66
680
(3019309) Folate [Moles/volume] in Red Blood Cells
678
6226
1.11
1.68
1.8
1.8
nmol/l
1249.1
1169.7
0.98
526
4626
(3011648) Oxygen content in Venous blood
37
244
1.52
1.65
3.6
2.3
%
10.1
10.9
0.62
37
244
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
88
678
1.31
1.63
1.5
1.9
mg/l
11.7
13.0
0.54
80
621
(3022217) INR in Platelet poor plasma by Coagulation assay
508
4602
1.12
1.61
28.4
28.7
inr
1.5
1.4
0.39
68
621
(3000919) Neutrophils/100 leukocytes in Pleural fluid
20
113
1.77
1.60
1.5
1.4
%
23.9
23.6
0.01
15
104
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
32
2.50
1.59
2.5
2.3
u/field
0.3
0.6
—
8
32
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
63
2.07
1.59
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
77
1.95
1.59
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
121
1.74
1.58
1.1
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
121
1.74
1.58
1.1
1.9
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.34
1.52
6.2
6.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
27
2.60
1.51
1.3
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
123
1.71
1.50
1.1
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
341
3030
1.14
1.49
2.9
2.9
ng/l
319.5
230.6
1.37
321
2770
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
32
210
1.53
1.48
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
298
2627
1.15
1.46
2.5
2.2
ug/g
265.4
159.1
0.74
235
2063
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
22
2.73
1.43
1.0
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
172
1.57
1.42
1.4
2.3
e6/l
467.0
547.6
0.41
19
150
(3003327) Ova and parasites identified in Stool by Light microscopy
87
684
1.28
1.42
2.0
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
29
2.42
1.39
1.0
1.0
—
—
—
0
0
(4133840)
12
60
2.00
1.38
1.3
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
151
1.59
1.34
2.1
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2561
25062
1.09
1.34
29.8
15.9
ml/min/173m2
61.7
75.2
152.89
2345
20791
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
40
0.00
1.32
0.0
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
46
334
1.38
1.31
3.6
3.8
%
57.6
58.0
0.04
35
204
(40768795) Lymph node Pathology biopsy report
37
259
1.43
1.29
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
169
1.54
1.28
2.6
3.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
26
169
1.54
1.28
1.2
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
50
370
1.36
1.27
1.2
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
116
0.43
1.25
1.2
1.3
—
1.3
—
0
7
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
25
163
1.54
1.22
1.5
2.3
e9/l
0.3
0.2
0.17
19
148
(3000494) Fungus identified in Specimen by Culture
364
3293
1.12
1.22
1.6
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2373
23188
1.08
1.21
30.3
18.1
%
37.9
39.2
6.50
1499
14985
(4034850)
72
908
0.79
1.21
18.2
11.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
909
1.22
1.20
1.4
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
29
197
1.48
1.19
1.2
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
26
173
1.51
1.17
1.5
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
40
290
1.38
1.17
3.5
3.1
mg/l
100.4
26.7
1.30
28
229
(3028026) IgM [Mass/volume] in Serum or Plasma
183
1589
1.16
1.15
2.2
1.8
g/l
1.9
1.4
0.63
165
1431
(3003338) MCHC [Mass/volume]
2092
21460
0.93
1.15
38.2
21.9
g/l
329.8
332.2
25.43
2074
21257
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
39
2.05
1.15
1.8
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
29
200
1.45
1.12
2.0
2.5
ph
7.4
7.4
0.38
11
71
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
183
0.55
1.11
1.3
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
20
127
1.58
1.11
1.5
1.5
%
1.1
2.4
1.11
15
107
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
20
127
1.58
1.11
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
66
1.82
1.09
3.7
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
136
1.55
1.08
1.3
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
82
1.71
1.05
1.4
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
46
1.96
1.03
1.1
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
59
464
1.28
1.03
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
119
1009
1.19
1.03
1.2
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
34
2.06
1.02
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
56
438
1.28
1.02
3.5
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
358
0.70
1.02
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
68
1.77
1.00
1.9
1.3
ug/l
12.5
9.2
1.01
12
68
(3008898) HLA-B27 [Presence]
45
583
0.77
0.98
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
223
1.39
0.98
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
130
1117
1.17
0.97
1.6
1.8
u/l
37.3
38.7
0.30
112
946
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
29
0.00
0.97
0.0
1.1
—
29.3
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
17
108
1.58
0.96
2.6
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
183
1615
1.14
0.96
2.4
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
216
1929
1.13
0.95
3.6
3.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
421
0.73
0.94
1.4
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
37
1.89
0.94
1.3
1.2
—
—
—
0
0
(44806420)
6
116
0.52
0.94
1.5
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
28
200
1.40
0.93
2.1
2.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
266
2410
1.11
0.92
2.2
2.2
nmol/l
11.7
12.6
0.93
227
2081
(3041354) Potassium [Moles/volume] in Venous blood
56
447
1.26
0.90
3.5
2.4
mmol/l
4.3
4.1
2.70
56
440
(3035285) Chloride [Moles/volume] in Venous blood
56
447
1.26
0.90
3.5
2.4
mmol/l
104.6
105.4
0.49
56
440
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2472
25134
0.94
0.89
7.2
6.4
mmol/mol
41.5
40.9
2.50
2273
22941
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2859
28231
1.08
0.89
37.0
19.8
umol/l
113.3
83.6
77.69
2859
28222
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
5
103
0.48
0.89
1.2
2.1
e6/l
7066.0
20166.6
—
5
64
(3013005) Retinol [Moles/volume] in Serum or Plasma
13
79
1.65
0.88
1.5
1.5
umol/l
2.3
1.9
0.81
13
72
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
683
6465
1.07
0.87
1.7
1.7
pmol/l
22678990.7
27157396.3
0.07
560
5262
(3048879) Bone marrow aspiration report
15
96
1.56
0.84
1.5
1.6
—
—
—
0
0
(4281824)
33
249
1.33
0.81
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
138
1.45
0.81
1.1
1.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
15
225
0.67
0.81
2.5
2.0
ug/l
15.8
3.3
—
10
193
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
22
156
1.41
0.78
2.4
2.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
66
1.67
0.78
1.5
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
59
1.70
0.75
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
76
642
1.19
0.74
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
100
865
1.16
0.74
6.5
4.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
108
1.48
0.73
1.2
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
60
1.67
0.72
1.2
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
84
1.55
0.71
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
68
1.62
0.71
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
76
1.58
0.71
1.1
1.1
miu/ml
775.1
1644.3
3.62
12
76
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
13
194
0.67
0.71
1.5
1.4
pmol/l
98.1
201.2
—
7
65
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
26
1.92
0.70
1.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
149
1332
1.12
0.70
1.3
1.3
u/ml
256.9
238.9
0.08
131
1211
(3014271) Vancomycin [Susceptibility]
25
186
1.35
0.70
2.8
3.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
102
890
1.15
0.69
1.7
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
85
1.53
0.68
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
114
1003
1.14
0.68
1.5
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
55
660
0.83
0.67
1.7
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
41
329
1.25
0.67
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
170
1.36
0.67
1.3
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
170
1.36
0.67
1.3
1.6
—
—
—
0
0
(4024509)
36
285
1.27
0.66
1.2
1.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
52
625
0.83
0.65
1.5
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
103
1.46
0.65
2.1
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
103
1.46
0.65
2.1
2.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
105
1.43
0.60
1.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
29
227
1.28
0.59
1.1
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
72
1.53
0.59
1.7
1.8
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
35
1.72
0.57
1.3
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
15
106
1.42
0.57
2.3
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
54
1.48
0.57
1.6
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
306
2868
1.07
0.56
1.4
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
23
176
1.31
0.56
1.7
2.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
42
347
1.21
0.56
2.5
3.9
u/ml
36.3
39.1
0.06
42
338
(4094501)
68
784
0.86
0.55
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
37
1.62
0.55
1.0
1.6
—
—
—
0
0
(4062490)
29
230
1.26
0.55
1.0
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
19
142
1.34
0.54
1.1
1.2
u/l
377.9
398.6
0.03
19
133
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
236
2535
0.93
0.54
1.4
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
182
0.71
0.54
1.2
1.2
mmol/l
17.1
12.2
—
5
61
(3016018) Differential panel - Cerebral spinal fluid
32
259
1.24
0.52
1.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
84
742
1.14
0.52
1.8
1.6
iu/ml
0.5
13.1
0.88
14
163
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
135
0.67
0.51
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
243
2600
0.93
0.51
1.6
1.8
%
1.6
1.6
0.03
206
2211
(3003740) Influenza virus B Ag [Presence] in Specimen
30
242
1.24
0.51
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
76
862
0.88
0.51
1.7
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
118
1.36
0.50
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
67
1.49
0.49
1.1
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
30
243
1.24
0.49
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
92
1027
0.89
0.48
1.1
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
46
1.52
0.48
1.1
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
234
0.77
0.48
1.1
1.1
u/ml
0.9
1.4
—
6
99
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
111
0.63
0.48
1.1
1.1
iu/ml
286.9
225.3
—
7
111
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2839
28157
1.05
0.48
17.6
11.1
u/l
27.9
26.4
0.42
2750
26979
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
43
364
1.18
0.47
1.0
1.2
miu/ml
86.9
202.1
—
10
122
(3023511) Choriogonadotropin [Units/volume] in Urine
10
68
1.47
0.47
1.3
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
118
0.68
0.45
1.3
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
228
1.23
0.45
1.0
1.3
g/l
6.8
6.9
0.09
18
162
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
228
1.23
0.45
1.0
1.3
g/l
2.7
2.9
0.25
18
162
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
228
1.23
0.45
1.0
1.3
g/l
0.4
0.4
0.37
17
162
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
201
1.25
0.44
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
31
256
1.21
0.44
1.6
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
51
1.37
0.44
1.0
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
32
383
0.83
0.43
3.3
4.5
umol/l
285.4
343.3
2.04
26
338
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
130
0.69
0.43
1.4
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
131
0.69
0.43
2.1
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
95
0.63
0.42
1.3
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
70
1.43
0.41
1.0
1.0
—
—
—
0
0
(4015189)
13
96
1.36
0.41
2.8
2.3
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
16
0.00
0.41
0.0
2.0
—
1.5
—
0
16
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
34
1.47
0.40
3.0
4.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
141
1.28
0.40
1.2
1.2
nmol/l
125.6
139.8
1.17
18
141
(3032868) Hemoglobin electrophoresis panel in Blood
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
59
521
1.13
0.40
1.3
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.4
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
59
665
0.89
0.39
4.1
3.6
mg/l
31.3
29.5
0.12
37
427
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
324
0.83
0.39
1.3
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
23
187
1.23
0.39
1.7
2.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
291
0.82
0.38
1.5
1.3
e6/l
41513.1
114862.1
0.74
14
206
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
760
7814
0.96
0.38
3.1
3.2
ug/l
0.9
0.8
0.95
581
5469
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
280
0.82
0.38
1.3
1.5
%
17.4
26.5
0.93
14
170
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
36
1.39
0.38
1.0
1.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
170
0.76
0.38
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
170
0.76
0.38
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
170
0.76
0.38
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
68
1.32
0.37
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
42
364
1.16
0.37
3.1
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1070
10932
0.97
0.37
4.4
4.5
%
23.3
22.0
2.07
584
5625
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
169
0.77
0.37
1.9
1.9
nmol/l
19.1
17.0
0.38
13
155
(3023487) Leukocytes [#/volume] in Peritoneal fluid
8
116
0.69
0.36
2.1
2.4
e6/l
1353.3
6630.3
—
8
91
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
135
0.74
0.36
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
321
0.84
0.36
1.6
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
90
1.33
0.35
1.7
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
76
0.66
0.35
1.4
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
74
816
0.90
0.35
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
35
301
1.16
0.35
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
41
358
1.15
0.34
1.5
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
17
210
0.81
0.33
1.1
1.1
u/ml
2.4
2.3
—
5
51
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
65
588
1.11
0.32
1.2
1.3
mmol/l
4.0
3.9
0.31
60
549
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
92
1.31
0.31
1.1
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
13
101
1.29
0.31
19.3
14.8
nmol/l
1589.8
1396.8
0.41
13
101
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
361
3746
0.96
0.31
1.2
1.2
u/ml
16.6
14.6
0.14
117
1341
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1382
13611
1.03
0.30
5.1
5.2
ug/l
3.4
3.9
0.31
1239
12127
(3010813) Leukocytes [#/volume] in Blood
2891
29059
0.97
0.30
42.6
24.4
e9/l
7.2
6.9
12.04
2833
28073
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
239
0.84
0.29
1.1
1.1
u/ml
7.5
4.3
—
6
116
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
66
601
1.10
0.29
1.7
1.5
nmol/l
1.0
0.8
1.33
58
489
(3000963) Hemoglobin [Mass/volume] in Blood
2891
29056
0.97
0.29
42.8
24.6
g/l
129.7
134.8
50.22
2862
28529
(3014051) Protein [Presence] in Urine by Test strip
75
688
1.09
0.29
2.2
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
171
1620
1.06
0.29
5.2
3.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2891
29051
0.97
0.28
42.6
24.4
e12/l
4.4
4.5
17.05
2834
28067
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
158
1.20
0.28
1.8
1.4
u/ml
0.5
1.3
0.62
13
82
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
2891
29049
0.97
0.27
42.4
24.3
fl
91.3
91.6
2.97
2859
28519
(3024263) Appearance of Synovial fluid
15
183
0.82
0.27
1.3
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
2891
29048
0.97
0.27
42.3
24.3
pg
30.1
30.5
17.80
2859
28519
(3007461) Platelets [#/volume] in Blood
2891
29046
0.97
0.27
42.6
24.4
e9/l
244.5
239.9
2.90
2842
28173
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
171
0.82
0.26
1.1
1.1
u/ml
3.5
2.1
—
5
64
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
72
0.69
0.26
1.0
1.4
g/l
30.5
25.4
—
5
56
(3015171) Extractable nuclear Ab [Units/volume] in Serum
90
839
1.07
0.25
1.2
1.2
u/ml
0.5
0.9
—
7
70
(3032773) Endomysium IgG Ab [Titer] in Serum
15
181
0.83
0.25
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
159
0.82
0.24
1.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
76
1.18
0.24
1.1
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
131
1240
1.06
0.24
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
84
0.71
0.24
2.5
3.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
24
209
1.15
0.22
1.0
1.1
—
84.6
—
0
8
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
733
7193
1.02
0.22
1.7
1.6
mmol/l
1.6
1.3
9.33
618
5938
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
95
0.74
0.22
1.6
1.8
ug/l
25.2
105.2
—
7
84
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
267
1.12
0.21
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
8.3
—
0
10
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
3.9
—
0
11
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
102
0.78
0.21
1.5
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
277
1.12
0.21
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
5.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
206
2137
0.96
0.20
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
99
1.21
0.19
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
387
3775
1.03
0.19
12.8
7.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
46
423
1.09
0.19
1.0
1.1
iu/ml
1.5
88.4
1.97
11
77
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
118
1.19
0.19
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
270
0.89
0.19
1.0
1.1
u/ml
3.0
2.0
—
9
109
(4211845)
13
154
0.84
0.19
4.7
4.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
53
1.13
0.18
1.3
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
12
100
1.20
0.18
1.8
1.3
—
0.3
—
0
9
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
61
1.15
0.17
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
58
542
1.07
0.17
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
52
484
1.08
0.17
1.5
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
62
1.13
0.17
1.4
1.1
%
77.1
88.8
—
7
55
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
371
3626
1.03
0.17
4.6
4.8
%
30.6
32.8
3.65
259
2371
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
66
0.76
0.17
4.4
7.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
28
253
1.11
0.16
1.1
1.2
nmol/l
334.2
339.8
0.05
21
201
(4146454)
39
359
1.09
0.16
2.7
2.6
—
—
—
0
0
(4306422)
34
311
1.09
0.16
1.1
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
69
1.16
0.16
1.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
256
0.90
0.16
1.4
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
125
1201
1.04
0.15
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
52
555
0.94
0.15
1.2
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
119
0.84
0.15
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
102
1.18
0.15
1.1
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
83
1.08
0.14
1.2
2.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
24
217
1.11
0.14
1.0
1.1
—
59.8
—
0
9
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
131
1.15
0.14
1.3
1.1
u/l
1.0
1.2
—
8
70
(3028707) Methadone [Presence] in Urine by Screen method
18
160
1.13
0.14
1.7
2.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
239
2332
1.03
0.13
1.5
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
73
766
0.95
0.13
3.0
3.1
nmol/l
0.8
0.8
0.22
55
585
(3016879) Cocaine [Presence] in Urine
34
315
1.08
0.13
1.6
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
55
581
0.95
0.13
1.1
1.1
u/ml
5.6
8.9
—
5
47
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
252
0.91
0.12
1.1
1.1
u/ml
18.7
2.6
—
5
84
(40768793) Breast Pathology biopsy report
47
443
1.06
0.12
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
152
1.12
0.12
1.2
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
33
307
1.08
0.12
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
156
0.90
0.10
1.0
1.1
u/ml
11.5
2.9
—
6
58
(4027681)
14
125
1.12
0.10
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
45
1.11
0.09
4.6
3.3
umol/l
46.4
41.9
—
5
36
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
38
360
1.06
0.09
1.7
1.5
%
77.7
62.3
2.47
27
221
(3023420) DNA double strand Ab [Units/volume] in Serum
22
237
0.93
0.09
1.1
1.2
—
28.2
—
0
11
(3035933) Granulocytes/100 leukocytes in Blood
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
6
55
1.09
0.08
1.3
1.3
—
116.6
—
0
10
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
496
4906
1.01
0.08
1.2
1.2
u/ml
1.9
1.8
0.03
115
1222
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
420
0.95
0.08
1.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
144
0.90
0.08
4.8
4.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
263
1.07
0.08
1.7
2.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
60
0.83
0.08
1.0
1.1
—
2.5
—
0
10
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
224
1.07
0.08
2.6
2.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
393
3976
0.99
0.08
1.3
1.3
iu/ml
41.7
38.1
0.14
117
1226
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
338
0.95
0.08
1.3
1.2
u/ml
2.3
3.4
0.48
12
112
(3034426) Prothrombin time (PT)
6
71
0.84
0.07
1.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
62
599
1.04
0.07
1.1
1.2
u/ml
3.1
7.9
—
9
93
(40757373) Influenza virus identified in Isolate
7
80
0.87
0.07
1.3
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
85
0.82
0.07
1.4
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
13
118
1.10
0.07
1.5
2.5
%
111.2
93.3
0.68
13
111
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
559
0.97
0.06
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
92
0.87
0.06
1.3
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
93
0.86
0.06
1.0
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
76
739
1.03
0.06
1.6
1.6
e6/l
11558.7
15010.4
0.62
58
524
(4268621)
21
224
0.94
0.06
2.2
2.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
36
376
0.96
0.06
1.4
1.6
g/l
1.2
0.9
0.41
25
292
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
315
0.95
0.06
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
131
0.92
0.05
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
33
316
1.04
0.05
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
177
1795
0.99
0.05
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
41
425
0.96
0.05
1.2
1.1
u/ml
56.9
42.1
—
8
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
59
606
0.97
0.05
1.5
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
74
723
1.02
0.05
5.1
3.4
mmol/l
7.2
7.7
0.99
74
704
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
282
0.96
0.04
1.4
1.2
mmol/l
7.4
7.6
0.12
20
206
(3013139) Helicobacter pylori Ag [Presence] in Stool
166
1640
1.01
0.04
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
35
338
1.04
0.04
1.6
1.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
121
1.07
0.03
1.8
1.5
ug/l
9.1
9.9
0.11
13
102
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
311
0.96
0.03
1.2
1.5
—
—
—
0
0
(4010399)
200
1981
1.01
0.03
1.4
1.4
—
—
—
0
0
(44813793)
14
131
1.07
0.03
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
112
1.07
0.03
1.6
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
16
152
1.05
0.02
1.4
1.6
u/l
5.2
7.7
1.23
11
130
(3028300) Cannabinoids [Presence] in Urine
35
341
1.03
0.02
1.6
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
35
341
1.03
0.02
1.6
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
91
900
1.01
0.02
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
60
591
1.02
0.02
1.1
1.2
u/ml
2.1
4.1
—
6
54
(3051593) INR in Capillary blood by Coagulation assay
18
173
1.04
0.01
13.3
13.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
71
717
0.99
0.01
1.7
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
10
94
1.06
0.01
2.2
1.9
u/l
14.9
50.3
—
10
88
(3007164) IgA [Mass/volume] in Serum or Plasma
447
4461
1.00
0.01
1.5
1.5
g/l
2.6
2.7
0.20
275
2625
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
116
0.95
0.00
1.2
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
184
1.03
0.00
3.2
3.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
34
334
1.02
0.00
1.6
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
76
766
0.99
0.00
5.0
3.3
mmol/l
1.6
1.7
0.18
76
745
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
58
577
1.01
0.00
1.4
1.4
e6/l
693.0
901.4
0.16
46
474
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
58
577
1.01
0.00
1.4
1.4
e6/l
54.9
26.3
0.25
46
450
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
108
1.02
0.00
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
220
1.00
0.00
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
110
1.00
0.00
1.2
1.6
umol/l
86.0
107.0
—
5
68
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
325
1.02
0.00
1.2
1.2
u/ml
3.4
5.3
0.62
16
150
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
56
557
1.01
0.00
1.8
1.9
pmol/l
222.5
203.8
0.63
51
522
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
80
1.00
0.00
26.9
7.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
78
0.90
0.00
1.6
2.3
ug/l
2.3
1.3
—
7
71
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
94
0.96
0.00
24.0
7.3
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
66
0.91
0.00
1.0
1.4
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
56
0.89
0.00
1.4
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
58
0.86
0.00
2.0
2.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
74
0.95
0.00
2.6
2.4
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
35.7
—
0
7
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
5
57
0.88
0.00
2.6
2.3
—
4.0
—
0
22
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
178.0
—
0
5
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
489.8
—
0
6
(3005033) Fetal Nuchal fold Thickness US
5
56
0.89
0.00
1.4
1.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
53
0.94
0.00
8.2
6.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
63
0.95
0.00
1.2
2.1
%
195.5
214.1
—
6
55
(3022689) Creatine [Moles/volume] in Urine
7
72
0.97
0.00
2.0
1.5
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.4
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
58
0.86
0.00
1.4
1.5
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
85
0.94
0.00
1.3
2.0
%
189.9
187.4
—
8
76
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
68
0.88
0.00
1.3
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_NOTRENALPELVIS – Malignant neoplasm of kidney, except renal pelvis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).